Clinical Trial Update: Evaluation of Non-typable Haemophilus Influenzae and Pneumococcal Protein Vaccine Formulations in Young Adults [Phase 1]

View source ↗

Summary

Phase 1 trial evaluating non-typable Haemophilus influenzae and Streptococcus pneumoniae protein vaccine formulations in young adults completed; results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Haemophilus Influenzae Infection
• Streptococcus Pneumoniae Infection

Drugs mentioned

• GlaxoSmithKline protein vaccine formulations (non-typable Haemophilus influenzae and Streptococcus pneumoniae)

Snippet

Sponsor: GlaxoSmithKline | Conditions: Streptococcus Pneumoniae, Haemophilus Influenzae | Phase 1 | Status: COMPLETED | Results posted: 2013-01-25